National Centre for Clinical Research on Emerging Drugs

2.0k papers and 104.5k indexed citations

About

In recent decades, authors affiliated with National Centre for Clinical Research on Emerging Drugs have published 2.0k papers, which have received a total of 104.5k indexed citations. Scholars at this organization have produced 932 papers in Epidemiology, 685 papers in Infectious Diseases and 393 papers in General Health Professions on the topics of HIV/AIDS Research and Interventions (524 papers), HIV, Drug Use, Sexual Risk (412 papers) and HIV Research and Treatment (376 papers). Their work is cited by papers focused on Epidemiology (44.2k citations), Infectious Diseases (31.5k citations) and Virology (17.9k citations). Authors at National Centre for Clinical Research on Emerging Drugs collaborate with scholars in Australia, United States and United Kingdom and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of National Centre for Clinical Research on Emerging Drugs's most productive authors include Wayne Hall, Louisa Degenhardt, John Kaldor, David A. Cooper, Matthew Law, Gregory J. Dore, Andrew Carr, Richard P. Mattick, Andrew E. Grulich and Susan Kippax.

In The Last Decade

National Centre for Clinical Research on Emerging Drugs

2.0k papers receiving 104.1k citations

Fields of papers published by authors at National Centre for Clinical Research on Emerging Drugs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with National Centre for Clinical Research on Emerging Drugs at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with National Centre for Clinical Research on Emerging Drugs at the time of their publication.

Countries citing scholars working at National Centre for Clinical Research on Emerging Drugs

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at National Centre for Clinical Research on Emerging Drugs. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at National Centre for Clinical Research on Emerging Drugs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites National Centre for Clinical Research on Emerging Drugs more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026